Early development service for microbial fermentation

Product Description
Boehringer Ingelheim Biopharmaceuticals GmbH

-
DE
-
2023On CPHI since
-
5000+Employees
Company types
Boehringer Ingelheim Biopharmaceuticals GmbH

-
DE
-
2023On CPHI since
-
5000+Employees
Company types
More Products from Boehringer Ingelheim Biopharmaceuticals GmbH (5)
-
Product Downstream Only - Processing for microbial derived proteins
Proven track record in ‘downstream- processing- only’ services Service description: - Intermediate materials, that need to be further purified and/or conjugated - Hormones or other recombinant proteins like virus like particles from inclusion bodies or from biomass - Peptides from inclusion bodies, biom... -
Product Tech Transfer
Efficient tech transfers from customers or within own global bio-manufacturing network, launch preparation and commercial supply readiness for drug substance and drug product. Service description: - Long-standing track record in product launches - 47 biopharmaceuticals brought to the market - Tailored to... -
Product Drug Substance Manufacturing - Mammalian Cell Cultures
• Around 430,000 L total commercial capacity for cell culture • Manufacturing sites around the globe: Biberach/Germany, Vienna/Austria, Fremont, CA/USA and Shanghai/ China- from 2,000 up to 15,000 L bioreactors • GMP facilities licensed by EMA, FDA, MHLW and other authorities ... -
Product Drug Substance Manufacturing - Microbial Fermentation
12,000 L commercial manufacturing capacity in multi-licensed facility Two trains each with 6,000 L of capacity which can be used with flexible scales
Large-scale GMP facilities licensed by EMA, FDA & MHLW for clinical and commercial global supplies
Protein refol... -
Product Aseptic Filling
• Clinical and commercial capacities and technology for vials • Formulations for liquids and lyophilizates vials (flexible vial sizes from 2 mL to 100 mL) • Flexible filling volumes for clinical and commercial supply • Manual and automated visual inspections • Globally licensed ...
Boehringer Ingelheim Biopharmaceuticals GmbH resources (4)
-
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
Whitepaper Advancements in microbial manufacturing of biopharmaceuticals
Advancements in Microbial Manufacturing of Biopharmaceuticals: A Historical Perspective and Future Outlook. -
Video New Cell Culture Facility in Vienna
We are is raising the bar with the LSCC (Large Scale Cell Culture), the new biopharmaceutical multi-product facility, in Vienna. It is one of the most modern buildings of its kind with a high degree of automation and flexibility.
Frequently Viewed Together
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance